Q32 Bio (QTTB) Free Cash Flow (2017 - 2026)

Q32 Bio's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$6.5 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 48.79% year-over-year to -$6.5 million; the TTM figure through Mar 2026 stood at -$28.3 million (up 57.04% YoY), while the FY2025 annual figure was -$34.5 million, up 49.1% from the prior year.
• Free Cash Flow was -$6.5 million for Q1 2026 at Q32 Bio, up from -$7.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $16.1 million in Q3 2023 to a low of -$32.1 million in Q2 2022.
• Historically, Free Cash Flow has averaged -$14.3 million across 5 years, with a median of -$12.5 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Free Cash Flow surged 164.53% in 2023, then sank 222.96% in 2024.
• A 5-year view of Free Cash Flow shows it stood at -$27.2 million in 2022, then jumped by 60.62% to -$10.7 million in 2023, then slipped by 1.74% to -$10.9 million in 2024, then surged by 34.49% to -$7.1 million in 2025, then grew by 8.72% to -$6.5 million in 2026.
• The last three Free Cash Flow figures came in at -$6.5 million (Q1 2026), -$7.1 million (Q4 2025), and -$4.2 million (Q3 2025), per Business Quant data.